Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cnossen

Showing results (321-330 of 442) with videos related to

Pageof 45
Sort By:
Blood|February 13, 2015
von Willebrand factor propeptide and the phenotypic classification of von Willebrand diseaseYvonne V Sanders, Dafna Groeneveld, Karina Meijer, et al.
Hemasphere|February 24, 2021
Von Willebrand Factor Multimer Densitometric Analysis: Validation of the Clinical Accuracy and Clinical Implications in Von Willebrand DiseaseJohan Boender, Ferdows Atiq, Marjon H Cnossen, et al.
Journal of Thrombosis and Haemostasis : JTH|September 27, 2019
One piece of the puzzle: Population pharmacokinetics of FVIII during perioperative Haemate P<sup>®</sup> /Humate P<sup>®</sup> treatment in von Willebrand disease patientsNico C B de Jager, Laura H Bukkems, Jessica M Heijdra, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 10, 2015
Joint surgery in von Willebrand disease: a multicentre cross-sectional studyK P M van Galen, K Meijer, H C Vogely, et al.
Research and Practice in Thrombosis and Haemostasis|December 1, 2021
Generic PROMIS item banks in adults with hemophilia for patient-reported outcome assessment: Feasibility, measurement properties, and relevanceIsolde A R Kuijlaars, Lorynn Teela, Lize F D van Vulpen, et al.
Blood Advances|March 8, 2021
Population pharmacokinetics of the von Willebrand factor-factor VIII interaction in patients with von Willebrand diseaseLaura H Bukkems, Jessica M Heijdra, Nico C B de Jager, et al.
Journal of Thrombosis and Haemostasis : JTH|December 30, 2015
Perioperative treatment of hemophilia A patients: blood group O patients are at risk of bleeding complicationsH C A M Hazendonk, J Lock, R A A Mathôt, et al.
The Journal of Urology|December 21, 2020
Hypothermia During Partial Nephrectomy for Patients with Renal Tumors: A Randomized Controlled TrialRodney H Breau, Dean A Fergusson, Greg Knoll, et al.
Journal of Thrombosis and Haemostasis : JTH|January 17, 2022
Treatment of patients with rare bleeding disorders in the Netherlands: Real-life data from the RBiN studyDominique P M S M Maas, Joline L Saes, Nicole M A Blijlevens, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 29, 2021
Social participation is reduced in type 3 Von Willebrand disease patients and in patients with a severe bleeding phenotypeEva K Kempers, Calvin B van Kwawegen, Joke de Meris, et al.
Pageof 45

Showing results (321-330 of 442) with videos related to

Sort By:
Pageof 45
Blood|February 13, 2015
von Willebrand factor propeptide and the phenotypic classification of von Willebrand diseaseYvonne V Sanders, Dafna Groeneveld, Karina Meijer, et al.
Hemasphere|February 24, 2021
Von Willebrand Factor Multimer Densitometric Analysis: Validation of the Clinical Accuracy and Clinical Implications in Von Willebrand DiseaseJohan Boender, Ferdows Atiq, Marjon H Cnossen, et al.
Journal of Thrombosis and Haemostasis : JTH|September 27, 2019
One piece of the puzzle: Population pharmacokinetics of FVIII during perioperative Haemate P<sup>®</sup> /Humate P<sup>®</sup> treatment in von Willebrand disease patientsNico C B de Jager, Laura H Bukkems, Jessica M Heijdra, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 10, 2015
Joint surgery in von Willebrand disease: a multicentre cross-sectional studyK P M van Galen, K Meijer, H C Vogely, et al.
Research and Practice in Thrombosis and Haemostasis|December 1, 2021
Generic PROMIS item banks in adults with hemophilia for patient-reported outcome assessment: Feasibility, measurement properties, and relevanceIsolde A R Kuijlaars, Lorynn Teela, Lize F D van Vulpen, et al.
Blood Advances|March 8, 2021
Population pharmacokinetics of the von Willebrand factor-factor VIII interaction in patients with von Willebrand diseaseLaura H Bukkems, Jessica M Heijdra, Nico C B de Jager, et al.
Journal of Thrombosis and Haemostasis : JTH|December 30, 2015
Perioperative treatment of hemophilia A patients: blood group O patients are at risk of bleeding complicationsH C A M Hazendonk, J Lock, R A A Mathôt, et al.
The Journal of Urology|December 21, 2020
Hypothermia During Partial Nephrectomy for Patients with Renal Tumors: A Randomized Controlled TrialRodney H Breau, Dean A Fergusson, Greg Knoll, et al.
Journal of Thrombosis and Haemostasis : JTH|January 17, 2022
Treatment of patients with rare bleeding disorders in the Netherlands: Real-life data from the RBiN studyDominique P M S M Maas, Joline L Saes, Nicole M A Blijlevens, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 29, 2021
Social participation is reduced in type 3 Von Willebrand disease patients and in patients with a severe bleeding phenotypeEva K Kempers, Calvin B van Kwawegen, Joke de Meris, et al.
Pageof 45